AI brief of an SEC Form 8-K · National Health Investors (NHI)

NHI agrees to sell NHC portfolio for $560 million, closing expected July 1, 2026

Mixed Impact 4 of 5 m&a Written later

National Health Investors agreed to sell 32 skilled nursing facilities and three independent living facilities to its lessee, National HealthCare Corporation, for $560.0 million. The company expects to close on July 1, 2026, subject to customary conditions including the Hart-Scott-Rodino waiting period, and plans to use net proceeds to repay borrowings and fund future investments. The filing says the 35 properties generated about $39.7 million of cash lease revenue in 2025, so shareholders will lose that income stream while gaining proceeds to reduce debt.

Key points

  • Sale of 32 skilled nursing facilities and three independent living facilities to NHC for $560.0 million.
  • Anticipated closing date of July 1, 2026, subject to customary conditions and HSR waiting period expiration or termination.
  • The 35 properties generated approximately $39.7 million of cash lease revenue in 2025, including percentage rent.
  • Expected transaction costs of $6.0 to $8.0 million; pro forma net debt-to-annualized EBITDA of about 2.3x and available liquidity of about $1.4 billion.

The filing

CompanyNational Health Investors (NHI)
Form8-K, current report
Filed with the SECApr 21, 2026, 4:27 PM ET
Accession number0000877860-26-000106

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.